Maintenance is scheduled for Tuesday, April 23, 2024, from 9:00 a.m. until 12:00 p.m. (ET). During this period there may be disruptions to the publications.gc.ca website.
Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older :...: HP40-160/2016E-PDF
"The objective of this Statement Update is to provide evidence and interim recommendations for the use of PNEU-C-13 in immunocompetent adults over 65 years of age and to allow informed decision making in cases when PNEU-C-13 is being considered on an individual basis for use in this age group. This statement: updates the epidemiology of pneumococcal disease in Canada for strains prevented by PNEU-C-13 to the year of the most recently available data (2013); provides an update to the review of the literature on the use of PNEU-C-13 in immunocompetent adults, which includes the recently published CAPiTA trial, as well as randomised controlled trials (RCTs) that investigate safety and immunogenicity; and provides updated, interim, recommendations for the use of PNEU-C-13 in immunocompetent individuals who are 65 years of age and over“--Introduction, p. 5.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.820810&sl=0
| Department/Agency | Canada. National Advisory Committee on Immunization. Public Health Agency of Canada. |
|---|---|
| Title | Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older : interim recommendation. |
| Variant title | At head of title: Advisory committee statement (ACS), National Advisory Committee on Immunization (NACI) |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Mise à jour sur l’utilisation du vaccin conjugué 13-valent (Pneu-C-13) en plus du vaccin polysaccharidique 23-valent contre le pneumocoque (Pneu-P-23) chez les adultes immunocompétents âgés de 65 ans et plus : recommandation provisoire. Includes bibliographical references. |
| Publishing information | [Ottawa] : Public Health Agency of Canada, 2016. |
| Description | 27 p. |
| ISBN | 978-0-660-05838-2 |
| Catalogue number |
|
| Departmental catalogue number | 160085 |
| Subject terms | Influenza Immunization Seniors |